| 40.0 |
720.3 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 37.9 |
151.7 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 37.7 |
603.9 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 34.6 |
172.9 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 34.1 |
204.6 |
GO:0061518 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 31.4 |
94.2 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 29.8 |
29.8 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 29.6 |
88.9 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 28.1 |
84.4 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 26.8 |
160.7 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 26.5 |
79.5 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 26.3 |
78.8 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 24.4 |
97.7 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 24.2 |
24.2 |
GO:0007602 |
phototransduction(GO:0007602) |
| 23.7 |
166.1 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 23.5 |
164.8 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 23.5 |
94.1 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 23.3 |
116.3 |
GO:0044858 |
plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 23.0 |
230.1 |
GO:0051610 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 22.6 |
22.6 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 22.6 |
67.8 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 22.3 |
67.0 |
GO:1902995 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 22.1 |
66.4 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 22.1 |
88.5 |
GO:0030185 |
nitric oxide transport(GO:0030185) |
| 21.3 |
128.0 |
GO:0052565 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 21.2 |
63.5 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 21.2 |
84.7 |
GO:1902612 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 21.1 |
21.1 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 21.0 |
62.9 |
GO:2000295 |
regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 20.9 |
187.7 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 20.8 |
41.7 |
GO:0002884 |
negative regulation of hypersensitivity(GO:0002884) |
| 19.2 |
57.6 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 19.0 |
75.9 |
GO:0003330 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 18.8 |
56.5 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 18.8 |
56.5 |
GO:0052026 |
modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 18.3 |
54.9 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 18.2 |
54.6 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 18.2 |
18.2 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 18.1 |
54.3 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 17.9 |
143.6 |
GO:0071673 |
positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 17.2 |
34.4 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 17.1 |
51.3 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 16.9 |
84.5 |
GO:0015688 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 16.8 |
218.7 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 16.7 |
83.3 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 16.4 |
49.3 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 16.4 |
65.7 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 16.2 |
16.2 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 16.2 |
32.4 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 16.2 |
97.0 |
GO:0072262 |
metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 16.2 |
48.5 |
GO:0035978 |
mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 15.9 |
95.4 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 15.7 |
47.1 |
GO:1904397 |
negative regulation of neuromuscular junction development(GO:1904397) |
| 15.6 |
15.6 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 15.5 |
46.4 |
GO:1902530 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 15.4 |
15.4 |
GO:2001074 |
regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 15.1 |
15.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 15.0 |
15.0 |
GO:0060353 |
regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
| 14.8 |
14.8 |
GO:1902229 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) negative regulation of response to DNA damage stimulus(GO:2001021) |
| 14.6 |
43.7 |
GO:1901731 |
positive regulation of platelet aggregation(GO:1901731) |
| 14.5 |
57.9 |
GO:0034443 |
negative regulation of lipoprotein oxidation(GO:0034443) |
| 14.5 |
57.9 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 14.4 |
14.4 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
| 14.4 |
86.6 |
GO:0010732 |
protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 14.4 |
115.2 |
GO:0070236 |
regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 14.3 |
43.0 |
GO:2000854 |
positive regulation of corticosterone secretion(GO:2000854) |
| 14.2 |
56.8 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 14.1 |
28.1 |
GO:0072131 |
kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) nephrogenic mesenchyme morphogenesis(GO:0072134) |
| 14.0 |
41.9 |
GO:0007439 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 13.9 |
41.8 |
GO:1904617 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 13.8 |
193.1 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 13.8 |
13.8 |
GO:0046660 |
female sex differentiation(GO:0046660) |
| 13.7 |
82.4 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 13.7 |
54.7 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 13.6 |
163.5 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 13.6 |
13.6 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 13.6 |
203.6 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 13.5 |
27.1 |
GO:0014859 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 13.5 |
53.9 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 13.4 |
67.2 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 13.1 |
39.3 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 13.1 |
13.1 |
GO:1904327 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 12.9 |
12.9 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 12.8 |
115.2 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 12.8 |
12.8 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 12.7 |
63.6 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 12.7 |
25.4 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 12.7 |
12.7 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 12.7 |
63.5 |
GO:1901908 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 12.7 |
50.8 |
GO:0019086 |
late viral transcription(GO:0019086) |
| 12.6 |
37.9 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 12.5 |
37.6 |
GO:0060915 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 12.5 |
50.0 |
GO:0042335 |
cuticle development(GO:0042335) |
| 12.4 |
62.0 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 12.4 |
37.1 |
GO:0021718 |
superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 12.3 |
110.9 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 12.3 |
49.3 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 12.2 |
73.4 |
GO:0032100 |
positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 12.1 |
48.5 |
GO:0003185 |
primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 12.1 |
24.2 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 12.1 |
48.3 |
GO:0035054 |
embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 12.0 |
60.0 |
GO:0030070 |
insulin processing(GO:0030070) |
| 12.0 |
48.0 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 12.0 |
35.9 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 12.0 |
71.8 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 12.0 |
35.9 |
GO:0001207 |
histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 12.0 |
71.7 |
GO:1902988 |
neurofibrillary tangle assembly(GO:1902988) |
| 12.0 |
167.3 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 11.9 |
35.8 |
GO:1902363 |
regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 11.8 |
11.8 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 11.8 |
118.4 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 11.8 |
47.3 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 11.8 |
47.3 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 11.8 |
23.6 |
GO:0070875 |
positive regulation of glycogen metabolic process(GO:0070875) |
| 11.8 |
11.8 |
GO:0051106 |
regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 11.8 |
47.1 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 11.8 |
47.1 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 11.7 |
58.7 |
GO:0033602 |
negative regulation of dopamine secretion(GO:0033602) |
| 11.7 |
35.0 |
GO:1990168 |
protein K33-linked deubiquitination(GO:1990168) |
| 11.6 |
46.5 |
GO:1903949 |
positive regulation of cardiac conduction(GO:1903781) positive regulation of atrial cardiac muscle cell action potential(GO:1903949) positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 11.6 |
11.6 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 11.5 |
34.6 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 11.5 |
11.5 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 11.5 |
22.9 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 11.4 |
45.6 |
GO:0060825 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 11.4 |
57.0 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 11.4 |
466.9 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 11.3 |
22.7 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 11.3 |
11.3 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 11.2 |
56.1 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 11.2 |
22.3 |
GO:0002865 |
negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 11.1 |
22.2 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 11.1 |
144.2 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 11.1 |
44.2 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 11.0 |
32.9 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 10.9 |
32.8 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 10.9 |
54.5 |
GO:0032849 |
positive regulation of cellular pH reduction(GO:0032849) |
| 10.8 |
54.2 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 10.8 |
21.6 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 10.8 |
53.8 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 10.7 |
10.7 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 10.7 |
10.7 |
GO:0035376 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 10.7 |
32.1 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 10.7 |
42.8 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 10.7 |
21.4 |
GO:0097018 |
renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
| 10.7 |
53.3 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 10.6 |
42.5 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 10.6 |
179.6 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 10.5 |
10.5 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 10.5 |
21.0 |
GO:2001190 |
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 10.5 |
31.4 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 10.5 |
41.8 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 10.4 |
10.4 |
GO:0003218 |
cardiac left ventricle formation(GO:0003218) |
| 10.4 |
62.6 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 10.4 |
83.0 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 10.4 |
20.7 |
GO:1904747 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 10.4 |
62.1 |
GO:0060613 |
fat pad development(GO:0060613) |
| 10.3 |
10.3 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 10.3 |
30.9 |
GO:0008286 |
insulin receptor signaling pathway(GO:0008286) |
| 10.3 |
10.3 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 10.2 |
10.2 |
GO:1900063 |
regulation of peroxisome organization(GO:1900063) |
| 10.2 |
10.2 |
GO:1901222 |
regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 10.2 |
40.8 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 10.2 |
30.6 |
GO:0002522 |
leukocyte migration involved in immune response(GO:0002522) |
| 10.1 |
81.1 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 10.1 |
30.4 |
GO:1902565 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 10.0 |
20.0 |
GO:0090182 |
regulation of secretion of lysosomal enzymes(GO:0090182) |
| 10.0 |
49.9 |
GO:0046113 |
nucleobase catabolic process(GO:0046113) |
| 10.0 |
79.8 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 10.0 |
39.9 |
GO:0048749 |
compound eye development(GO:0048749) |
| 9.9 |
29.8 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 9.9 |
79.4 |
GO:0098870 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 9.9 |
9.9 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 9.9 |
9.9 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 9.8 |
29.5 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 9.8 |
39.3 |
GO:2001151 |
regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 9.8 |
39.3 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 9.8 |
19.6 |
GO:0098758 |
response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 9.8 |
49.0 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 9.8 |
9.8 |
GO:0006983 |
ER overload response(GO:0006983) |
| 9.7 |
58.0 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 9.7 |
38.7 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 9.6 |
77.0 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 9.6 |
28.9 |
GO:0036309 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 9.6 |
28.8 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 9.6 |
28.8 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 9.6 |
19.1 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 9.5 |
66.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 9.5 |
133.0 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 9.5 |
47.3 |
GO:0036369 |
transcription factor catabolic process(GO:0036369) |
| 9.4 |
28.3 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 9.4 |
46.8 |
GO:0060406 |
positive regulation of penile erection(GO:0060406) |
| 9.4 |
18.7 |
GO:0021780 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 9.3 |
56.0 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 9.3 |
46.6 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 9.3 |
27.8 |
GO:0072244 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 9.2 |
18.5 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 9.2 |
18.3 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 9.1 |
27.4 |
GO:0050798 |
activated T cell proliferation(GO:0050798) |
| 9.1 |
27.4 |
GO:0038188 |
cholecystokinin signaling pathway(GO:0038188) |
| 9.1 |
9.1 |
GO:0015870 |
acetylcholine transport(GO:0015870) |
| 9.1 |
99.8 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 9.0 |
18.1 |
GO:0034441 |
plasma lipoprotein particle oxidation(GO:0034441) |
| 9.0 |
45.0 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 9.0 |
45.0 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 8.9 |
8.9 |
GO:0042710 |
biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 8.9 |
44.6 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 8.9 |
17.8 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) |
| 8.9 |
62.3 |
GO:0006562 |
proline catabolic process(GO:0006562) |
| 8.9 |
26.7 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 8.9 |
26.6 |
GO:0002265 |
astrocyte activation involved in immune response(GO:0002265) |
| 8.9 |
17.7 |
GO:0035962 |
response to interleukin-13(GO:0035962) |
| 8.9 |
26.6 |
GO:0002399 |
MHC class II protein complex assembly(GO:0002399) |
| 8.9 |
26.6 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 8.8 |
35.3 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
| 8.8 |
35.2 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 8.8 |
131.4 |
GO:0022010 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 8.8 |
26.3 |
GO:1904204 |
regulation of skeletal muscle hypertrophy(GO:1904204) |
| 8.8 |
61.3 |
GO:0045007 |
depurination(GO:0045007) |
| 8.8 |
376.4 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 8.7 |
8.7 |
GO:0034442 |
regulation of lipoprotein oxidation(GO:0034442) |
| 8.7 |
8.7 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 8.7 |
69.4 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 8.7 |
8.7 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 8.6 |
95.0 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 8.6 |
17.2 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 8.6 |
25.9 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 8.5 |
25.6 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 8.5 |
17.0 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 8.5 |
203.4 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 8.4 |
33.7 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 8.4 |
8.4 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 8.4 |
25.2 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 8.4 |
75.5 |
GO:0097647 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 8.3 |
24.9 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 8.3 |
49.6 |
GO:1900239 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 8.3 |
41.3 |
GO:2000638 |
regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 8.2 |
24.7 |
GO:1902809 |
skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 8.2 |
16.4 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 8.2 |
32.7 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 8.2 |
40.9 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 8.2 |
40.8 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 8.1 |
8.1 |
GO:0032304 |
negative regulation of icosanoid secretion(GO:0032304) |
| 8.1 |
89.1 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 8.1 |
16.1 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 8.0 |
32.1 |
GO:1904978 |
regulation of endosome organization(GO:1904978) |
| 8.0 |
32.1 |
GO:0030822 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 8.0 |
48.1 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 8.0 |
8.0 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 8.0 |
55.7 |
GO:0002414 |
immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 7.9 |
55.4 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) |
| 7.9 |
31.7 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 7.9 |
23.7 |
GO:0002881 |
negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 7.9 |
31.5 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 7.9 |
23.6 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 7.9 |
39.3 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 7.8 |
7.8 |
GO:0010645 |
regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 7.8 |
54.8 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 7.8 |
85.8 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) |
| 7.8 |
31.2 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 7.8 |
15.6 |
GO:1902949 |
positive regulation of tau-protein kinase activity(GO:1902949) |
| 7.8 |
23.4 |
GO:0100009 |
regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 7.8 |
7.8 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 7.8 |
23.3 |
GO:0071140 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 7.8 |
15.5 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 7.7 |
7.7 |
GO:1904304 |
regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
| 7.7 |
23.2 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 7.7 |
61.5 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 7.7 |
7.7 |
GO:1990641 |
response to iron ion starvation(GO:1990641) |
| 7.7 |
46.0 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 7.6 |
15.3 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 7.6 |
22.9 |
GO:0060029 |
convergent extension involved in organogenesis(GO:0060029) |
| 7.6 |
15.2 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 7.6 |
7.6 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 7.6 |
7.6 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 7.6 |
7.6 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 7.6 |
7.6 |
GO:0014032 |
neural crest cell migration(GO:0001755) neural crest cell development(GO:0014032) |
| 7.6 |
91.0 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 7.6 |
7.6 |
GO:0043634 |
polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 7.6 |
45.3 |
GO:0051410 |
detoxification of nitrogen compound(GO:0051410) |
| 7.5 |
37.6 |
GO:0001957 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 7.5 |
7.5 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 7.5 |
7.5 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 7.5 |
45.1 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 7.5 |
7.5 |
GO:1902303 |
negative regulation of potassium ion export(GO:1902303) |
| 7.5 |
67.6 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 7.5 |
37.5 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 7.5 |
37.4 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 7.5 |
44.8 |
GO:0021853 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 7.5 |
22.4 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 7.4 |
29.8 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 7.4 |
22.3 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 7.4 |
22.3 |
GO:0010902 |
positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 7.4 |
66.7 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 7.4 |
7.4 |
GO:0034626 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation(GO:0030497) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) very long-chain fatty acid biosynthetic process(GO:0042761) |
| 7.3 |
51.4 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 7.3 |
36.7 |
GO:1901523 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 7.3 |
7.3 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 7.3 |
29.2 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 7.2 |
21.7 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 7.2 |
7.2 |
GO:0051885 |
positive regulation of anagen(GO:0051885) |
| 7.2 |
21.6 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 7.2 |
35.9 |
GO:0036414 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 7.2 |
14.3 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 7.2 |
21.5 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 7.2 |
21.5 |
GO:0097359 |
UDP-glucosylation(GO:0097359) |
| 7.2 |
57.2 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 7.1 |
7.1 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 7.1 |
21.3 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 7.1 |
21.3 |
GO:0015888 |
thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 7.1 |
7.1 |
GO:0071878 |
negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
| 7.1 |
7.1 |
GO:0050863 |
regulation of T cell activation(GO:0050863) |
| 7.1 |
7.1 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 7.1 |
98.9 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 7.1 |
56.5 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 7.1 |
14.1 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 7.0 |
14.1 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 7.0 |
7.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 7.0 |
7.0 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 7.0 |
63.0 |
GO:0072102 |
glomerulus morphogenesis(GO:0072102) |
| 7.0 |
21.0 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) |
| 7.0 |
14.0 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 7.0 |
20.9 |
GO:0051710 |
regulation of cytolysis in other organism(GO:0051710) |
| 7.0 |
20.9 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 7.0 |
20.9 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 7.0 |
180.7 |
GO:0097503 |
sialylation(GO:0097503) |
| 6.9 |
34.7 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 6.9 |
173.2 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 6.9 |
13.9 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 6.9 |
6.9 |
GO:0046951 |
cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) ketone body metabolic process(GO:1902224) |
| 6.9 |
48.2 |
GO:1903977 |
positive regulation of glial cell migration(GO:1903977) |
| 6.9 |
13.8 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 6.9 |
6.9 |
GO:2000366 |
regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 6.8 |
6.8 |
GO:0001743 |
optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
| 6.8 |
6.8 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 6.8 |
27.3 |
GO:1905146 |
lysosomal protein catabolic process(GO:1905146) |
| 6.8 |
27.2 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 6.8 |
20.4 |
GO:0070142 |
synaptic vesicle budding(GO:0070142) |
| 6.8 |
6.8 |
GO:0009624 |
response to nematode(GO:0009624) |
| 6.8 |
27.2 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 6.8 |
27.1 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 6.8 |
6.8 |
GO:0007497 |
posterior midgut development(GO:0007497) |
| 6.7 |
27.0 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 6.7 |
54.0 |
GO:0007320 |
insemination(GO:0007320) |
| 6.7 |
80.8 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 6.7 |
13.4 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 6.7 |
20.1 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 6.7 |
20.1 |
GO:0014744 |
positive regulation of muscle adaptation(GO:0014744) |
| 6.7 |
13.4 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 6.7 |
20.1 |
GO:0021999 |
neural plate anterior/posterior regionalization(GO:0021999) |
| 6.7 |
53.5 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 6.7 |
26.7 |
GO:0060313 |
negative regulation of blood vessel remodeling(GO:0060313) |
| 6.7 |
40.0 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 6.6 |
19.9 |
GO:0001766 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 6.6 |
6.6 |
GO:0070093 |
negative regulation of glucagon secretion(GO:0070093) |
| 6.6 |
13.2 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 6.6 |
92.4 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 6.6 |
6.6 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 6.6 |
26.2 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 6.6 |
52.4 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 6.5 |
6.5 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 6.5 |
39.2 |
GO:0036017 |
response to erythropoietin(GO:0036017) cellular response to erythropoietin(GO:0036018) |
| 6.5 |
52.3 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 6.5 |
52.3 |
GO:0006531 |
aspartate metabolic process(GO:0006531) |
| 6.5 |
26.0 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 6.5 |
6.5 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 6.5 |
26.0 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 6.5 |
26.0 |
GO:0051121 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 6.5 |
19.4 |
GO:0060023 |
soft palate development(GO:0060023) |
| 6.5 |
6.5 |
GO:2000538 |
regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 6.4 |
12.9 |
GO:1902564 |
negative regulation of neutrophil activation(GO:1902564) |
| 6.4 |
32.2 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 6.4 |
19.3 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 6.4 |
19.3 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 6.4 |
38.5 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 6.4 |
6.4 |
GO:0002071 |
glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
| 6.4 |
12.8 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 6.4 |
12.7 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 6.4 |
25.4 |
GO:0060664 |
epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 6.4 |
31.8 |
GO:0071874 |
cellular response to norepinephrine stimulus(GO:0071874) |
| 6.4 |
25.4 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) |
| 6.3 |
12.7 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 6.3 |
12.7 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 6.3 |
19.0 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 6.3 |
12.6 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 6.3 |
25.3 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 6.3 |
31.6 |
GO:0060197 |
cloacal septation(GO:0060197) |
| 6.3 |
37.8 |
GO:0001554 |
luteolysis(GO:0001554) |
| 6.3 |
37.7 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 6.3 |
18.8 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 6.3 |
37.6 |
GO:0002760 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 6.3 |
50.1 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 6.3 |
12.5 |
GO:0016572 |
histone phosphorylation(GO:0016572) |
| 6.3 |
68.8 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 6.2 |
37.5 |
GO:0048710 |
regulation of astrocyte differentiation(GO:0048710) positive regulation of astrocyte differentiation(GO:0048711) |
| 6.2 |
43.7 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 6.2 |
74.8 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 6.2 |
31.2 |
GO:0033084 |
regulation of immature T cell proliferation in thymus(GO:0033084) |
| 6.2 |
12.5 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 6.2 |
31.1 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 6.2 |
68.5 |
GO:0060746 |
maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 6.2 |
6.2 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 6.2 |
18.5 |
GO:0061055 |
myotome development(GO:0061055) |
| 6.2 |
24.7 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 6.1 |
6.1 |
GO:0098915 |
potassium ion export across plasma membrane(GO:0097623) membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 6.1 |
73.5 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 6.1 |
24.5 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 6.1 |
48.8 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 6.1 |
12.2 |
GO:0031959 |
mineralocorticoid receptor signaling pathway(GO:0031959) |
| 6.1 |
24.3 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 6.1 |
12.1 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 6.1 |
36.3 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 6.0 |
6.0 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 6.0 |
48.3 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 6.0 |
12.1 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 6.0 |
6.0 |
GO:0015669 |
gas transport(GO:0015669) |
| 6.0 |
18.1 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 6.0 |
6.0 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 6.0 |
12.0 |
GO:1902938 |
regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 6.0 |
35.9 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 6.0 |
23.8 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 6.0 |
29.8 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 5.9 |
11.8 |
GO:1903036 |
positive regulation of response to wounding(GO:1903036) |
| 5.9 |
23.6 |
GO:0003343 |
proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 5.9 |
5.9 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 5.9 |
29.5 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 5.9 |
64.9 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 5.9 |
5.9 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 5.9 |
5.9 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) positive regulation of heat generation(GO:0031652) |
| 5.9 |
11.8 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 5.9 |
17.7 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 5.9 |
17.7 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 5.9 |
41.1 |
GO:0042426 |
choline catabolic process(GO:0042426) |
| 5.8 |
5.8 |
GO:0097384 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) cellular lipid biosynthetic process(GO:0097384) |
| 5.8 |
17.4 |
GO:1902430 |
negative regulation of beta-amyloid formation(GO:1902430) |
| 5.8 |
17.4 |
GO:0032223 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 5.8 |
34.8 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 5.8 |
52.1 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 5.8 |
23.1 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 5.8 |
63.3 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 5.8 |
28.8 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 5.7 |
34.4 |
GO:0072364 |
regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 5.7 |
51.2 |
GO:0021895 |
cerebral cortex neuron differentiation(GO:0021895) |
| 5.7 |
17.1 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 5.7 |
11.3 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 5.7 |
84.9 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 5.7 |
17.0 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 5.6 |
28.2 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 5.6 |
33.9 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 5.6 |
45.0 |
GO:0021794 |
thalamus development(GO:0021794) |
| 5.6 |
16.8 |
GO:0019557 |
histidine catabolic process(GO:0006548) histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) imidazole-containing compound catabolic process(GO:0052805) |
| 5.6 |
61.7 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 5.6 |
5.6 |
GO:0002224 |
toll-like receptor signaling pathway(GO:0002224) |
| 5.6 |
16.8 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 5.6 |
27.9 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 5.6 |
27.9 |
GO:0072233 |
thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 5.5 |
11.1 |
GO:0007418 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 5.5 |
132.8 |
GO:0008038 |
neuron recognition(GO:0008038) |
| 5.5 |
60.9 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 5.5 |
49.8 |
GO:0015747 |
urate transport(GO:0015747) |
| 5.5 |
27.7 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 5.5 |
38.7 |
GO:0010641 |
positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 5.5 |
11.0 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 5.5 |
5.5 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 5.5 |
16.4 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 5.5 |
10.9 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 5.5 |
32.7 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 5.4 |
32.7 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 5.4 |
16.3 |
GO:0002731 |
negative regulation of dendritic cell cytokine production(GO:0002731) |
| 5.4 |
21.7 |
GO:1900193 |
regulation of oocyte maturation(GO:1900193) |
| 5.4 |
70.5 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 5.4 |
5.4 |
GO:0034371 |
chylomicron remodeling(GO:0034371) |
| 5.4 |
102.8 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 5.4 |
5.4 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 5.4 |
16.2 |
GO:0003147 |
neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
| 5.4 |
16.1 |
GO:0030320 |
cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
| 5.4 |
26.8 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 5.3 |
32.1 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 5.3 |
5.3 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 5.3 |
21.3 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 5.3 |
5.3 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 5.3 |
37.3 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 5.3 |
16.0 |
GO:0098935 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 5.3 |
5.3 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 5.3 |
10.6 |
GO:0042746 |
regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 5.3 |
26.6 |
GO:0099538 |
synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 5.3 |
31.8 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 5.3 |
15.9 |
GO:0002371 |
dendritic cell cytokine production(GO:0002371) |
| 5.3 |
21.2 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 5.3 |
58.2 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 5.3 |
15.9 |
GO:0038178 |
complement component C5a signaling pathway(GO:0038178) |
| 5.3 |
10.6 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 5.3 |
63.2 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 5.3 |
10.5 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
| 5.3 |
99.9 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
| 5.2 |
36.7 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 5.2 |
41.9 |
GO:0090494 |
dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 5.2 |
31.3 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 5.2 |
31.3 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 5.2 |
15.6 |
GO:0052047 |
interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 5.2 |
88.6 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 5.2 |
20.8 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 5.2 |
10.4 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 5.2 |
62.4 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 5.2 |
31.2 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 5.2 |
15.6 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 5.2 |
20.7 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 5.2 |
5.2 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 5.2 |
10.3 |
GO:1902732 |
positive regulation of chondrocyte proliferation(GO:1902732) |
| 5.1 |
25.7 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 5.1 |
20.6 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 5.1 |
25.6 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 5.1 |
20.5 |
GO:0006540 |
glutamate decarboxylation to succinate(GO:0006540) |
| 5.1 |
56.2 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 5.1 |
15.3 |
GO:1902022 |
lysine transport(GO:0015819) L-lysine transport(GO:1902022) |
| 5.1 |
10.2 |
GO:1990164 |
histone H2A phosphorylation(GO:1990164) |
| 5.1 |
5.1 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 5.1 |
25.3 |
GO:0034128 |
negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 5.1 |
70.9 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 5.0 |
25.2 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 5.0 |
60.4 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 5.0 |
5.0 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 5.0 |
25.1 |
GO:0051029 |
rRNA transport(GO:0051029) |
| 5.0 |
20.0 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 5.0 |
20.0 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 5.0 |
5.0 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) |
| 5.0 |
5.0 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 5.0 |
165.1 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 5.0 |
34.9 |
GO:0055009 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 5.0 |
10.0 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 5.0 |
49.8 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 5.0 |
39.8 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 5.0 |
10.0 |
GO:0086068 |
Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 5.0 |
34.8 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 5.0 |
54.5 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 4.9 |
49.5 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 4.9 |
9.9 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 4.9 |
9.8 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 4.9 |
24.5 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 4.9 |
24.5 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 4.9 |
4.9 |
GO:0001975 |
response to amphetamine(GO:0001975) |
| 4.9 |
4.9 |
GO:0035801 |
adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 4.9 |
9.8 |
GO:1900673 |
olefin metabolic process(GO:1900673) |
| 4.9 |
9.8 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 4.9 |
29.2 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 4.9 |
14.6 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 4.8 |
14.5 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 4.8 |
87.1 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 4.8 |
4.8 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 4.8 |
28.9 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 4.8 |
120.2 |
GO:0035249 |
synaptic transmission, glutamatergic(GO:0035249) |
| 4.8 |
4.8 |
GO:0008291 |
acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 4.8 |
62.2 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 4.8 |
9.6 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 4.8 |
9.6 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 4.8 |
4.8 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) |
| 4.8 |
9.5 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 4.8 |
62.0 |
GO:0035878 |
nail development(GO:0035878) |
| 4.8 |
4.8 |
GO:0060599 |
lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
| 4.8 |
19.0 |
GO:2000342 |
negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 4.8 |
14.3 |
GO:0007509 |
mesoderm migration involved in gastrulation(GO:0007509) |
| 4.8 |
38.1 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 4.7 |
61.7 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 4.7 |
47.4 |
GO:0051791 |
medium-chain fatty acid metabolic process(GO:0051791) |
| 4.7 |
4.7 |
GO:0010663 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 4.7 |
23.6 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 4.7 |
37.7 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 4.7 |
14.1 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 4.7 |
28.3 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 4.7 |
18.6 |
GO:0032431 |
activation of phospholipase A2 activity(GO:0032431) |
| 4.6 |
27.8 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 4.6 |
120.5 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 4.6 |
13.9 |
GO:0070781 |
response to biotin(GO:0070781) |
| 4.6 |
9.2 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 4.6 |
23.0 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 4.6 |
18.4 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 4.6 |
18.4 |
GO:0090009 |
primitive streak formation(GO:0090009) |
| 4.6 |
55.0 |
GO:0038065 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
| 4.6 |
9.2 |
GO:1903798 |
regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
| 4.6 |
9.1 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 4.6 |
27.4 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 4.6 |
4.6 |
GO:0086091 |
regulation of heart rate by cardiac conduction(GO:0086091) |
| 4.6 |
9.1 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 4.6 |
13.7 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 4.5 |
27.3 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 4.5 |
27.3 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 4.5 |
18.2 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 4.5 |
9.1 |
GO:0061624 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 4.5 |
9.0 |
GO:0072237 |
metanephric proximal tubule development(GO:0072237) |
| 4.5 |
18.0 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 4.5 |
22.4 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 4.5 |
13.5 |
GO:1990519 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 4.5 |
13.5 |
GO:2000698 |
positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
| 4.5 |
4.5 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 4.5 |
9.0 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 4.5 |
22.3 |
GO:0071422 |
succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 4.5 |
4.5 |
GO:0033861 |
negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 4.4 |
22.2 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 4.4 |
4.4 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 4.4 |
57.4 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 4.4 |
13.2 |
GO:0045906 |
negative regulation of vasoconstriction(GO:0045906) |
| 4.4 |
39.6 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 4.4 |
8.8 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 4.4 |
13.2 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 4.4 |
8.8 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 4.4 |
52.5 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 4.4 |
4.4 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 4.4 |
13.1 |
GO:0070105 |
regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 4.4 |
26.2 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 4.3 |
13.0 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 4.3 |
13.0 |
GO:0072672 |
neutrophil extravasation(GO:0072672) |
| 4.3 |
95.0 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 4.3 |
17.2 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 4.3 |
12.9 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 4.3 |
25.7 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 4.3 |
21.4 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 4.3 |
34.2 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 4.3 |
17.1 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 4.2 |
29.7 |
GO:0046465 |
dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 4.2 |
21.2 |
GO:0061734 |
parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 4.2 |
25.4 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 4.2 |
12.7 |
GO:0098810 |
neurotransmitter reuptake(GO:0098810) |
| 4.2 |
8.4 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 4.2 |
16.8 |
GO:1902572 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 4.2 |
29.4 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 4.2 |
25.2 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 4.2 |
12.6 |
GO:0090191 |
negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 4.2 |
4.2 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 4.2 |
12.5 |
GO:2000020 |
positive regulation of male gonad development(GO:2000020) |
| 4.2 |
29.2 |
GO:0046520 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 4.2 |
25.0 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 4.2 |
100.0 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 4.2 |
4.2 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 4.2 |
54.1 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 4.2 |
25.0 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 4.2 |
4.2 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 4.2 |
29.1 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 4.2 |
54.0 |
GO:0060831 |
smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 4.1 |
24.9 |
GO:1901525 |
negative regulation of macromitophagy(GO:1901525) |
| 4.1 |
4.1 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 4.1 |
28.9 |
GO:0009407 |
toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 4.1 |
28.9 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 4.1 |
12.4 |
GO:1904849 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 4.1 |
12.4 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 4.1 |
8.2 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 4.1 |
16.4 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 4.1 |
12.3 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 4.1 |
61.5 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 4.1 |
24.6 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 4.1 |
8.2 |
GO:1901876 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 4.1 |
24.5 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 4.1 |
8.1 |
GO:0070861 |
regulation of protein exit from endoplasmic reticulum(GO:0070861) positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 4.1 |
105.8 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 4.1 |
28.5 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 4.1 |
4.1 |
GO:0039533 |
regulation of MDA-5 signaling pathway(GO:0039533) positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 4.0 |
20.2 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 4.0 |
8.1 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 4.0 |
16.1 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 4.0 |
4.0 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 4.0 |
32.1 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 4.0 |
24.1 |
GO:0031649 |
heat generation(GO:0031649) |
| 4.0 |
8.0 |
GO:0034086 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 4.0 |
20.0 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 4.0 |
4.0 |
GO:0042249 |
establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 4.0 |
15.9 |
GO:2000391 |
positive regulation of neutrophil extravasation(GO:2000391) |
| 4.0 |
51.8 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 4.0 |
8.0 |
GO:0010959 |
regulation of metal ion transport(GO:0010959) |
| 4.0 |
4.0 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 4.0 |
31.8 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 4.0 |
4.0 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 4.0 |
27.7 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 4.0 |
7.9 |
GO:0090520 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 4.0 |
98.8 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 3.9 |
47.4 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 3.9 |
94.7 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 3.9 |
7.9 |
GO:0044252 |
negative regulation of collagen metabolic process(GO:0010713) negative regulation of multicellular organismal metabolic process(GO:0044252) |
| 3.9 |
11.8 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 3.9 |
3.9 |
GO:0003007 |
heart morphogenesis(GO:0003007) |
| 3.9 |
15.7 |
GO:0050962 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 3.9 |
3.9 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 3.9 |
7.8 |
GO:0006692 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 3.9 |
15.6 |
GO:0038001 |
paracrine signaling(GO:0038001) |
| 3.9 |
15.6 |
GO:2000672 |
regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 3.9 |
27.3 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 3.9 |
15.6 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 3.9 |
7.8 |
GO:0050482 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 3.9 |
15.6 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 3.9 |
3.9 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 3.9 |
23.3 |
GO:0071105 |
response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 3.9 |
31.0 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 3.9 |
7.7 |
GO:0060454 |
positive regulation of gastric acid secretion(GO:0060454) |
| 3.9 |
7.7 |
GO:0072007 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) |
| 3.9 |
27.0 |
GO:0015840 |
urea transport(GO:0015840) |
| 3.8 |
57.7 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 3.8 |
19.2 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 3.8 |
11.5 |
GO:0071073 |
positive regulation of phospholipid biosynthetic process(GO:0071073) |
| 3.8 |
19.2 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 3.8 |
26.8 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 3.8 |
57.2 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 3.8 |
19.0 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 3.8 |
7.6 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 3.8 |
3.8 |
GO:2000410 |
regulation of thymocyte migration(GO:2000410) |
| 3.8 |
15.0 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 3.8 |
3.8 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 3.8 |
11.3 |
GO:1903038 |
negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
| 3.7 |
14.9 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 3.7 |
11.2 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 3.7 |
11.2 |
GO:0042377 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 3.7 |
11.2 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 3.7 |
3.7 |
GO:0051446 |
positive regulation of meiotic cell cycle(GO:0051446) |
| 3.7 |
11.2 |
GO:1903121 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
| 3.7 |
3.7 |
GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 3.7 |
3.7 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 3.7 |
37.1 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 3.7 |
7.4 |
GO:0002778 |
antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 3.7 |
55.0 |
GO:0042551 |
neuron maturation(GO:0042551) |
| 3.7 |
18.3 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 3.7 |
18.3 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 3.7 |
65.8 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 3.6 |
14.6 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 3.6 |
7.3 |
GO:0030825 |
positive regulation of cGMP metabolic process(GO:0030825) |
| 3.6 |
14.6 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 3.6 |
14.6 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 3.6 |
3.6 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 3.6 |
3.6 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) |
| 3.6 |
32.6 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 3.6 |
3.6 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 3.6 |
7.2 |
GO:0001942 |
hair follicle development(GO:0001942) |
| 3.6 |
32.5 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 3.6 |
18.0 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 3.6 |
18.0 |
GO:1901090 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 3.6 |
10.8 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 3.6 |
46.7 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 3.6 |
14.3 |
GO:0035712 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 3.6 |
7.2 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 3.6 |
39.4 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 3.6 |
10.7 |
GO:0021571 |
rhombomere 5 development(GO:0021571) |
| 3.6 |
25.0 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 3.6 |
14.3 |
GO:0031018 |
endocrine pancreas development(GO:0031018) |
| 3.6 |
7.1 |
GO:0060168 |
regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 3.6 |
49.8 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 3.5 |
7.1 |
GO:1901162 |
primary amino compound biosynthetic process(GO:1901162) |
| 3.5 |
42.5 |
GO:0002438 |
acute inflammatory response to antigenic stimulus(GO:0002438) |
| 3.5 |
17.7 |
GO:0099563 |
modification of synaptic structure(GO:0099563) |
| 3.5 |
3.5 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 3.5 |
60.0 |
GO:0046928 |
regulation of neurotransmitter secretion(GO:0046928) |
| 3.5 |
3.5 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 3.5 |
7.0 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 3.5 |
24.5 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 3.5 |
28.0 |
GO:0045905 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 3.5 |
10.5 |
GO:0008628 |
hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 3.5 |
13.9 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 3.5 |
13.9 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 3.5 |
13.9 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 3.5 |
59.1 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 3.5 |
10.4 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 3.5 |
13.8 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 3.4 |
37.9 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 3.4 |
6.9 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 3.4 |
10.3 |
GO:0043605 |
cellular amide catabolic process(GO:0043605) |
| 3.4 |
3.4 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 3.4 |
20.5 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 3.4 |
3.4 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 3.4 |
16.9 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 3.4 |
23.7 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 3.4 |
50.6 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 3.4 |
16.9 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 3.4 |
16.8 |
GO:0070862 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 3.4 |
40.3 |
GO:0002029 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 3.4 |
30.2 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 3.4 |
20.1 |
GO:0090042 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 3.4 |
13.4 |
GO:1903441 |
protein localization to ciliary membrane(GO:1903441) |
| 3.3 |
70.3 |
GO:0035338 |
long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 3.3 |
3.3 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 3.3 |
10.0 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 3.3 |
3.3 |
GO:0042693 |
muscle cell fate commitment(GO:0042693) |
| 3.3 |
16.6 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 3.3 |
26.5 |
GO:0042308 |
negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
| 3.3 |
3.3 |
GO:0042231 |
interleukin-13 biosynthetic process(GO:0042231) |
| 3.3 |
49.6 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 3.3 |
9.9 |
GO:0035931 |
mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 3.3 |
9.9 |
GO:0060452 |
positive regulation of cardiac muscle contraction(GO:0060452) |
| 3.3 |
9.9 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 3.3 |
3.3 |
GO:1902361 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 3.3 |
3.3 |
GO:0033025 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 3.3 |
32.7 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 3.3 |
6.5 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 3.3 |
6.5 |
GO:1905123 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) regulation of glucosylceramidase activity(GO:1905123) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 3.3 |
26.1 |
GO:0006111 |
regulation of gluconeogenesis(GO:0006111) |
| 3.3 |
35.8 |
GO:0042737 |
drug catabolic process(GO:0042737) |
| 3.2 |
71.5 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 3.2 |
25.9 |
GO:0017185 |
peptidyl-lysine hydroxylation(GO:0017185) |
| 3.2 |
6.5 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) entrainment of circadian clock by photoperiod(GO:0043153) |
| 3.2 |
16.0 |
GO:0072530 |
purine-containing compound transmembrane transport(GO:0072530) |
| 3.2 |
12.8 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 3.2 |
12.8 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 3.2 |
9.5 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 3.2 |
28.5 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 3.2 |
6.3 |
GO:0032233 |
positive regulation of actin filament bundle assembly(GO:0032233) |
| 3.1 |
6.3 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 3.1 |
9.4 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 3.1 |
44.0 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 3.1 |
3.1 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 3.1 |
18.8 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 3.1 |
9.4 |
GO:0060687 |
regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
| 3.1 |
9.4 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 3.1 |
12.5 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 3.1 |
3.1 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 3.1 |
6.2 |
GO:0051142 |
regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 3.1 |
6.2 |
GO:0014848 |
urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 3.1 |
18.6 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 3.1 |
9.3 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 3.1 |
24.7 |
GO:0050974 |
detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 3.1 |
30.9 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 3.1 |
9.3 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 3.1 |
12.3 |
GO:0098707 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 3.1 |
3.1 |
GO:0061152 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 3.1 |
27.5 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 3.1 |
73.3 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 3.0 |
6.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 3.0 |
106.6 |
GO:0019226 |
transmission of nerve impulse(GO:0019226) |
| 3.0 |
6.1 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 3.0 |
75.9 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 3.0 |
6.1 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 3.0 |
78.8 |
GO:0060291 |
long-term synaptic potentiation(GO:0060291) |
| 3.0 |
9.1 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 3.0 |
6.1 |
GO:0002687 |
positive regulation of leukocyte migration(GO:0002687) |
| 3.0 |
24.2 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 3.0 |
3.0 |
GO:0070943 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 3.0 |
12.0 |
GO:2000479 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 3.0 |
30.1 |
GO:0010882 |
regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
| 3.0 |
30.0 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 3.0 |
9.0 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 3.0 |
6.0 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 3.0 |
6.0 |
GO:0052803 |
imidazole-containing compound metabolic process(GO:0052803) |
| 3.0 |
48.0 |
GO:0031646 |
positive regulation of neurological system process(GO:0031646) |
| 3.0 |
3.0 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 3.0 |
12.0 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 3.0 |
44.9 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 3.0 |
47.8 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 3.0 |
3.0 |
GO:1900107 |
regulation of nodal signaling pathway(GO:1900107) |
| 3.0 |
20.9 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 3.0 |
3.0 |
GO:0070988 |
demethylation(GO:0070988) |
| 3.0 |
8.9 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 3.0 |
8.9 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 3.0 |
5.9 |
GO:0051917 |
regulation of fibrinolysis(GO:0051917) |
| 3.0 |
3.0 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 2.9 |
35.3 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 2.9 |
14.7 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 2.9 |
11.7 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 2.9 |
5.9 |
GO:0044062 |
regulation of excretion(GO:0044062) |
| 2.9 |
5.8 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 2.9 |
17.5 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 2.9 |
29.1 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 2.9 |
14.6 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 2.9 |
69.9 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 2.9 |
69.9 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 2.9 |
8.7 |
GO:0060453 |
regulation of gastric acid secretion(GO:0060453) |
| 2.9 |
23.3 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 2.9 |
17.4 |
GO:0048243 |
norepinephrine secretion(GO:0048243) |
| 2.9 |
26.1 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 2.9 |
43.4 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 2.9 |
17.4 |
GO:0052055 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 2.9 |
20.2 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 2.9 |
83.7 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 2.9 |
14.4 |
GO:0046852 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 2.9 |
11.5 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 2.9 |
14.4 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 2.9 |
17.3 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 2.9 |
5.8 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 2.9 |
166.7 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 2.9 |
5.7 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 2.9 |
17.1 |
GO:2000535 |
regulation of entry of bacterium into host cell(GO:2000535) |
| 2.9 |
5.7 |
GO:0015791 |
polyol transport(GO:0015791) |
| 2.8 |
11.4 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 2.8 |
8.5 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 2.8 |
2.8 |
GO:1903044 |
protein localization to membrane raft(GO:1903044) |
| 2.8 |
34.0 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 2.8 |
2.8 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 2.8 |
11.3 |
GO:0001714 |
endodermal cell fate specification(GO:0001714) |
| 2.8 |
25.4 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 2.8 |
8.5 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 2.8 |
2.8 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 2.8 |
8.4 |
GO:0051715 |
cytolysis in other organism(GO:0051715) |
| 2.8 |
5.6 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 2.8 |
19.6 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 2.8 |
5.6 |
GO:0050932 |
regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
| 2.8 |
8.3 |
GO:0000730 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 2.8 |
11.1 |
GO:0036124 |
histone H3-K9 trimethylation(GO:0036124) |
| 2.8 |
2.8 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 2.8 |
5.5 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 2.8 |
2.8 |
GO:0060335 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 2.8 |
5.5 |
GO:0046653 |
folic acid-containing compound metabolic process(GO:0006760) tetrahydrofolate metabolic process(GO:0046653) |
| 2.8 |
19.3 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 2.8 |
11.0 |
GO:1905225 |
thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) response to thyrotropin-releasing hormone(GO:1905225) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 2.7 |
126.3 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 2.7 |
8.2 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 2.7 |
2.7 |
GO:0034138 |
toll-like receptor 3 signaling pathway(GO:0034138) |
| 2.7 |
5.4 |
GO:0003011 |
involuntary skeletal muscle contraction(GO:0003011) |
| 2.7 |
5.4 |
GO:0031670 |
cellular response to nutrient(GO:0031670) |
| 2.7 |
10.8 |
GO:0046320 |
regulation of fatty acid oxidation(GO:0046320) |
| 2.7 |
13.5 |
GO:1902731 |
negative regulation of chondrocyte proliferation(GO:1902731) |
| 2.7 |
75.5 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 2.7 |
8.1 |
GO:0001759 |
organ induction(GO:0001759) |
| 2.7 |
8.1 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 2.7 |
5.4 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 2.7 |
26.8 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 2.7 |
18.8 |
GO:0090314 |
positive regulation of protein targeting to membrane(GO:0090314) |
| 2.7 |
5.4 |
GO:1904430 |
negative regulation of t-circle formation(GO:1904430) |
| 2.7 |
16.1 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 2.7 |
5.3 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 2.7 |
2.7 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) |
| 2.7 |
8.0 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 2.7 |
10.7 |
GO:0021578 |
hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
| 2.7 |
2.7 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 2.7 |
13.3 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 2.7 |
13.3 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 2.7 |
18.6 |
GO:0060850 |
regulation of transcription involved in cell fate commitment(GO:0060850) |
| 2.6 |
7.9 |
GO:0042253 |
granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) |
| 2.6 |
2.6 |
GO:0051348 |
negative regulation of transferase activity(GO:0051348) |
| 2.6 |
5.3 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 2.6 |
2.6 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 2.6 |
52.5 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 2.6 |
15.7 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 2.6 |
13.1 |
GO:0001825 |
blastocyst formation(GO:0001825) |
| 2.6 |
23.5 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 2.6 |
5.2 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 2.6 |
10.4 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 2.6 |
13.0 |
GO:1904098 |
regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 2.6 |
7.7 |
GO:0042791 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 2.6 |
5.2 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 2.6 |
5.2 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 2.6 |
25.8 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 2.6 |
7.7 |
GO:0034694 |
response to prostaglandin(GO:0034694) |
| 2.6 |
12.9 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 2.6 |
12.9 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 2.6 |
5.1 |
GO:0070092 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 2.6 |
10.3 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 2.6 |
10.2 |
GO:0042226 |
interleukin-6 biosynthetic process(GO:0042226) |
| 2.6 |
7.7 |
GO:0001555 |
oocyte growth(GO:0001555) |
| 2.5 |
5.1 |
GO:0007350 |
blastoderm segmentation(GO:0007350) |
| 2.5 |
7.6 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 2.5 |
12.7 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 2.5 |
7.6 |
GO:0035247 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 2.5 |
2.5 |
GO:0007620 |
copulation(GO:0007620) |
| 2.5 |
7.6 |
GO:0055074 |
calcium ion homeostasis(GO:0055074) |
| 2.5 |
5.0 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 2.5 |
7.5 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 2.5 |
5.0 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 2.5 |
12.5 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 2.5 |
10.0 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 2.5 |
17.5 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 2.5 |
5.0 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
| 2.5 |
25.0 |
GO:0090292 |
nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 2.5 |
10.0 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 2.5 |
17.4 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 2.5 |
14.9 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 2.5 |
22.3 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 2.5 |
22.2 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 2.5 |
160.2 |
GO:0044243 |
multicellular organism catabolic process(GO:0044243) |
| 2.5 |
2.5 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 2.4 |
22.0 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 2.4 |
4.9 |
GO:0045056 |
transcytosis(GO:0045056) |
| 2.4 |
4.9 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 2.4 |
7.3 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
| 2.4 |
133.0 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 2.4 |
2.4 |
GO:0097300 |
programmed necrotic cell death(GO:0097300) |
| 2.4 |
4.8 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 2.4 |
26.5 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 2.4 |
41.0 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 2.4 |
7.2 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 2.4 |
7.2 |
GO:0030856 |
regulation of epithelial cell differentiation(GO:0030856) |
| 2.4 |
2.4 |
GO:0006720 |
isoprenoid metabolic process(GO:0006720) |
| 2.4 |
19.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 2.4 |
33.6 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 2.4 |
7.2 |
GO:0045229 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 2.4 |
9.5 |
GO:0051930 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 2.4 |
2.4 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 2.4 |
45.0 |
GO:0021954 |
central nervous system neuron development(GO:0021954) |
| 2.4 |
4.7 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 2.4 |
4.7 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 2.3 |
11.7 |
GO:0042904 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 2.3 |
14.0 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 2.3 |
7.0 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 2.3 |
7.0 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 2.3 |
2.3 |
GO:0010935 |
regulation of macrophage cytokine production(GO:0010935) |
| 2.3 |
9.3 |
GO:0016233 |
telomere capping(GO:0016233) |
| 2.3 |
7.0 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 2.3 |
2.3 |
GO:0007612 |
learning(GO:0007612) |
| 2.3 |
4.6 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 2.3 |
2.3 |
GO:1990868 |
apoptotic process involved in outflow tract morphogenesis(GO:0003275) paraxial mesoderm formation(GO:0048341) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 2.3 |
11.4 |
GO:1990822 |
basic amino acid transmembrane transport(GO:1990822) |
| 2.3 |
22.8 |
GO:0010863 |
positive regulation of phospholipase C activity(GO:0010863) |
| 2.3 |
11.4 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 2.3 |
6.8 |
GO:0021904 |
dorsal/ventral neural tube patterning(GO:0021904) |
| 2.3 |
6.8 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 2.2 |
11.2 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 2.2 |
2.2 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 2.2 |
11.2 |
GO:0042983 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 2.2 |
22.3 |
GO:0034695 |
response to prostaglandin E(GO:0034695) |
| 2.2 |
2.2 |
GO:1904016 |
response to Thyroglobulin triiodothyronine(GO:1904016) |
| 2.2 |
4.5 |
GO:2000330 |
interleukin-23-mediated signaling pathway(GO:0038155) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
| 2.2 |
11.1 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 2.2 |
37.6 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 2.2 |
2.2 |
GO:0000101 |
sulfur amino acid transport(GO:0000101) |
| 2.2 |
4.4 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 2.2 |
4.4 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 2.2 |
15.3 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 2.2 |
8.8 |
GO:0003299 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 2.2 |
4.4 |
GO:2000980 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 2.2 |
6.6 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) |
| 2.2 |
21.8 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 2.2 |
10.8 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 2.2 |
2.2 |
GO:0042698 |
ovulation cycle(GO:0042698) |
| 2.2 |
4.3 |
GO:0060445 |
branching involved in salivary gland morphogenesis(GO:0060445) |
| 2.2 |
2.2 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 2.1 |
10.7 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 2.1 |
2.1 |
GO:0042116 |
macrophage activation(GO:0042116) |
| 2.1 |
2.1 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 2.1 |
6.4 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 2.1 |
27.8 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 2.1 |
57.6 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 2.1 |
42.6 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 2.1 |
4.3 |
GO:0086053 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 2.1 |
10.6 |
GO:0034656 |
nucleobase-containing small molecule catabolic process(GO:0034656) |
| 2.1 |
6.4 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 2.1 |
2.1 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 2.1 |
6.3 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 2.1 |
8.4 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 2.1 |
4.2 |
GO:0090306 |
spindle assembly involved in female meiosis(GO:0007056) spindle assembly involved in meiosis(GO:0090306) |
| 2.1 |
16.8 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 2.1 |
6.3 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 2.1 |
2.1 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 2.1 |
6.3 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 2.1 |
2.1 |
GO:0050955 |
thermoception(GO:0050955) |
| 2.1 |
14.6 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 2.1 |
8.3 |
GO:0098795 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
| 2.1 |
16.6 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 2.1 |
2.1 |
GO:0051147 |
regulation of muscle cell differentiation(GO:0051147) |
| 2.1 |
8.3 |
GO:0050890 |
cognition(GO:0050890) |
| 2.1 |
6.2 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 2.1 |
8.2 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 2.0 |
6.1 |
GO:0060677 |
ureteric bud elongation(GO:0060677) |
| 2.0 |
4.1 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 2.0 |
6.1 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 2.0 |
74.9 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 2.0 |
30.4 |
GO:0015879 |
carnitine shuttle(GO:0006853) carnitine transport(GO:0015879) carnitine transmembrane transport(GO:1902603) |
| 2.0 |
12.1 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 2.0 |
6.0 |
GO:0097049 |
motor neuron apoptotic process(GO:0097049) |
| 2.0 |
12.0 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 2.0 |
4.0 |
GO:0055075 |
potassium ion homeostasis(GO:0055075) |
| 2.0 |
2.0 |
GO:0097267 |
omega-hydroxylase P450 pathway(GO:0097267) |
| 2.0 |
2.0 |
GO:0030149 |
sphingolipid catabolic process(GO:0030149) |
| 2.0 |
3.9 |
GO:0006837 |
serotonin transport(GO:0006837) |
| 2.0 |
2.0 |
GO:0030317 |
sperm motility(GO:0030317) |
| 2.0 |
11.8 |
GO:0043647 |
inositol phosphate metabolic process(GO:0043647) |
| 2.0 |
3.9 |
GO:0018027 |
peptidyl-lysine dimethylation(GO:0018027) |
| 2.0 |
7.9 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 2.0 |
11.8 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 2.0 |
3.9 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 2.0 |
13.7 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 2.0 |
9.8 |
GO:1902219 |
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 2.0 |
2.0 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 2.0 |
5.9 |
GO:0007616 |
long-term memory(GO:0007616) |
| 2.0 |
2.0 |
GO:0002155 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 2.0 |
5.9 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 1.9 |
21.3 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 1.9 |
32.8 |
GO:0050771 |
negative regulation of axonogenesis(GO:0050771) |
| 1.9 |
17.3 |
GO:0030815 |
negative regulation of cAMP metabolic process(GO:0030815) |
| 1.9 |
13.4 |
GO:0006833 |
water transport(GO:0006833) |
| 1.9 |
9.5 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 1.9 |
41.9 |
GO:0046323 |
glucose import(GO:0046323) |
| 1.9 |
13.3 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 1.9 |
7.6 |
GO:0002827 |
positive regulation of T-helper 1 type immune response(GO:0002827) positive regulation of T-helper 1 cell differentiation(GO:0045627) negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 1.9 |
17.0 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
| 1.9 |
11.4 |
GO:0042723 |
thiamine-containing compound metabolic process(GO:0042723) |
| 1.9 |
3.8 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 1.9 |
7.5 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 1.9 |
18.8 |
GO:1904779 |
regulation of protein localization to centrosome(GO:1904779) |
| 1.9 |
3.8 |
GO:0048867 |
stem cell fate determination(GO:0048867) |
| 1.9 |
13.1 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 1.9 |
99.1 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 1.9 |
1.9 |
GO:0032042 |
mitochondrial DNA metabolic process(GO:0032042) |
| 1.9 |
5.6 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 1.9 |
1.9 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 1.9 |
7.4 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 1.8 |
3.7 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 1.8 |
3.7 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 1.8 |
32.9 |
GO:0033673 |
negative regulation of kinase activity(GO:0033673) |
| 1.8 |
54.7 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 1.8 |
10.9 |
GO:0007512 |
adult heart development(GO:0007512) |
| 1.8 |
1.8 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
| 1.8 |
12.6 |
GO:1990035 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 1.8 |
7.2 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 1.8 |
1.8 |
GO:1901978 |
positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) |
| 1.8 |
7.2 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 1.8 |
17.9 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 1.8 |
7.1 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 1.8 |
1.8 |
GO:0043114 |
regulation of vascular permeability(GO:0043114) |
| 1.8 |
7.1 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 1.8 |
12.3 |
GO:0010962 |
regulation of glycogen biosynthetic process(GO:0005979) regulation of glucan biosynthetic process(GO:0010962) |
| 1.7 |
8.7 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 1.7 |
1.7 |
GO:1903729 |
regulation of plasma membrane organization(GO:1903729) |
| 1.7 |
7.0 |
GO:0070997 |
neuron death(GO:0070997) |
| 1.7 |
10.5 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 1.7 |
12.2 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 1.7 |
15.7 |
GO:0051194 |
positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 1.7 |
1.7 |
GO:0010966 |
regulation of phosphate transport(GO:0010966) |
| 1.7 |
5.2 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 1.7 |
3.4 |
GO:0010891 |
regulation of sequestering of triglyceride(GO:0010889) negative regulation of sequestering of triglyceride(GO:0010891) sequestering of triglyceride(GO:0030730) |
| 1.7 |
12.0 |
GO:0034644 |
cellular response to UV(GO:0034644) cellular response to light stimulus(GO:0071482) |
| 1.7 |
5.1 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 1.7 |
6.8 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 1.7 |
5.1 |
GO:0035524 |
proline transmembrane transport(GO:0035524) |
| 1.7 |
26.9 |
GO:0006942 |
regulation of striated muscle contraction(GO:0006942) |
| 1.7 |
5.0 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 1.7 |
1.7 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 1.7 |
13.3 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 1.7 |
28.3 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) |
| 1.7 |
1.7 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 1.7 |
18.2 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 1.6 |
19.6 |
GO:0033622 |
integrin activation(GO:0033622) |
| 1.6 |
3.3 |
GO:0038109 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 1.6 |
17.9 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 1.6 |
6.5 |
GO:0006565 |
L-serine catabolic process(GO:0006565) |
| 1.6 |
3.2 |
GO:0010970 |
establishment of localization by movement along microtubule(GO:0010970) |
| 1.6 |
1.6 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 1.6 |
68.9 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 1.6 |
1.6 |
GO:0010813 |
neuropeptide catabolic process(GO:0010813) |
| 1.6 |
3.2 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 1.6 |
4.8 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 1.6 |
12.7 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 1.6 |
3.2 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 1.6 |
9.5 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 1.6 |
1.6 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 1.6 |
1.6 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 1.6 |
3.2 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 1.6 |
17.5 |
GO:0003341 |
cilium movement(GO:0003341) |
| 1.6 |
1.6 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 1.6 |
15.7 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 1.6 |
6.3 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 1.6 |
1.6 |
GO:0051403 |
stress-activated MAPK cascade(GO:0051403) |
| 1.6 |
20.3 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 1.6 |
9.3 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 1.6 |
183.4 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 1.6 |
3.1 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 1.6 |
4.7 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 1.6 |
20.2 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 1.5 |
24.8 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 1.5 |
4.6 |
GO:0051852 |
disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 1.5 |
4.6 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 1.5 |
18.4 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 1.5 |
1.5 |
GO:0051208 |
sequestering of calcium ion(GO:0051208) |
| 1.5 |
15.3 |
GO:0006896 |
Golgi to vacuole transport(GO:0006896) |
| 1.5 |
6.0 |
GO:0043087 |
regulation of GTPase activity(GO:0043087) |
| 1.5 |
6.0 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 1.5 |
15.0 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 1.5 |
4.5 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 1.5 |
11.9 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 1.5 |
10.4 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 1.5 |
1.5 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 1.5 |
20.7 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 1.5 |
1.5 |
GO:0017158 |
regulation of calcium ion-dependent exocytosis(GO:0017158) |
| 1.5 |
5.9 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 1.5 |
7.3 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 1.5 |
11.7 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 1.4 |
1.4 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 1.4 |
4.3 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 1.4 |
5.7 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 1.4 |
4.3 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 1.4 |
4.3 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 1.4 |
12.7 |
GO:0071276 |
cellular response to cadmium ion(GO:0071276) |
| 1.4 |
66.5 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 1.4 |
7.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 1.4 |
1.4 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 1.4 |
9.8 |
GO:0055002 |
striated muscle cell development(GO:0055002) |
| 1.4 |
7.0 |
GO:1900116 |
extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 1.4 |
7.0 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 1.4 |
4.2 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 1.4 |
2.8 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 1.4 |
2.8 |
GO:1903019 |
negative regulation of glycoprotein metabolic process(GO:1903019) |
| 1.4 |
4.2 |
GO:0046838 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 1.4 |
6.9 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 1.4 |
2.8 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 1.4 |
5.5 |
GO:1901318 |
negative regulation of sperm motility(GO:1901318) |
| 1.4 |
2.8 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 1.4 |
2.7 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 1.4 |
6.9 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) S-adenosylhomocysteine metabolic process(GO:0046498) |
| 1.4 |
1.4 |
GO:0060285 |
cilium-dependent cell motility(GO:0060285) |
| 1.4 |
4.1 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 1.4 |
6.8 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 1.3 |
9.4 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 1.3 |
8.0 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 1.3 |
2.7 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 1.3 |
4.0 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 1.3 |
1.3 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 1.3 |
4.0 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 1.3 |
8.0 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 1.3 |
9.3 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 1.3 |
39.8 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 1.3 |
14.5 |
GO:0032094 |
response to food(GO:0032094) |
| 1.3 |
10.6 |
GO:0007040 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 1.3 |
1.3 |
GO:0032645 |
granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) |
| 1.3 |
1.3 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.3 |
735.6 |
GO:0043547 |
positive regulation of GTPase activity(GO:0043547) |
| 1.3 |
11.6 |
GO:0010762 |
regulation of fibroblast migration(GO:0010762) |
| 1.3 |
14.1 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 1.3 |
5.1 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 1.3 |
1.3 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 1.3 |
1.3 |
GO:1901072 |
glucosamine-containing compound catabolic process(GO:1901072) |
| 1.3 |
2.5 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 1.3 |
12.6 |
GO:1902222 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 1.3 |
18.9 |
GO:0097435 |
fibril organization(GO:0097435) |
| 1.3 |
10.1 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 1.2 |
2.5 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 1.2 |
3.7 |
GO:1901142 |
insulin metabolic process(GO:1901142) |
| 1.2 |
1.2 |
GO:0002724 |
regulation of T cell cytokine production(GO:0002724) |
| 1.2 |
6.2 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 1.2 |
7.4 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 1.2 |
7.4 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 1.2 |
3.7 |
GO:0030194 |
positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
| 1.2 |
6.1 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 1.2 |
3.7 |
GO:0031076 |
embryonic camera-type eye development(GO:0031076) |
| 1.2 |
3.6 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 1.2 |
1.2 |
GO:0034435 |
steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 1.2 |
4.8 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 1.2 |
9.6 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 1.2 |
20.3 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 1.2 |
1.2 |
GO:0009233 |
menaquinone metabolic process(GO:0009233) |
| 1.2 |
11.9 |
GO:0001754 |
eye photoreceptor cell differentiation(GO:0001754) |
| 1.2 |
8.3 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 1.2 |
4.7 |
GO:0060840 |
artery development(GO:0060840) |
| 1.2 |
2.4 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 1.2 |
4.7 |
GO:0030916 |
otic vesicle formation(GO:0030916) otic vesicle morphogenesis(GO:0071600) |
| 1.2 |
2.3 |
GO:0090154 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 1.2 |
80.7 |
GO:0006836 |
neurotransmitter transport(GO:0006836) |
| 1.2 |
147.2 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 1.2 |
22.2 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 1.2 |
7.0 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 1.2 |
18.5 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 1.2 |
3.5 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 1.1 |
1.1 |
GO:0051604 |
protein maturation(GO:0051604) |
| 1.1 |
6.9 |
GO:0007618 |
mating(GO:0007618) |
| 1.1 |
2.3 |
GO:0001767 |
establishment of lymphocyte polarity(GO:0001767) |
| 1.1 |
5.7 |
GO:0009757 |
hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) regulation of glucose mediated signaling pathway(GO:1902659) |
| 1.1 |
15.7 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 1.1 |
1.1 |
GO:0045829 |
negative regulation of isotype switching(GO:0045829) |
| 1.1 |
6.7 |
GO:0048296 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 1.1 |
6.7 |
GO:0019374 |
galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 1.1 |
2.2 |
GO:0070272 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 1.1 |
7.8 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 1.1 |
1.1 |
GO:0002577 |
regulation of antigen processing and presentation(GO:0002577) |
| 1.1 |
2.2 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 1.1 |
1.1 |
GO:0034343 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 1.1 |
9.8 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 1.1 |
3.3 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 1.1 |
2.2 |
GO:0097242 |
beta-amyloid clearance(GO:0097242) |
| 1.1 |
1.1 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 1.1 |
1.1 |
GO:0045623 |
negative regulation of T-helper cell differentiation(GO:0045623) |
| 1.1 |
4.3 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 1.1 |
7.5 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 1.1 |
1.1 |
GO:0030917 |
midbrain-hindbrain boundary development(GO:0030917) |
| 1.1 |
12.7 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 1.1 |
15.9 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 1.1 |
6.3 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 1.1 |
5.3 |
GO:0060512 |
prostate gland morphogenesis(GO:0060512) |
| 1.1 |
7.4 |
GO:0060397 |
JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 1.0 |
1.0 |
GO:0032760 |
positive regulation of tumor necrosis factor production(GO:0032760) |
| 1.0 |
1.0 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 1.0 |
35.6 |
GO:0007422 |
peripheral nervous system development(GO:0007422) |
| 1.0 |
5.2 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 1.0 |
4.2 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 1.0 |
3.1 |
GO:0099504 |
synaptic vesicle cycle(GO:0099504) |
| 1.0 |
1.0 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 1.0 |
11.4 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 1.0 |
3.1 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.0 |
4.1 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 1.0 |
18.3 |
GO:0045332 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 1.0 |
2.0 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 1.0 |
2.0 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 1.0 |
2.0 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 1.0 |
2.0 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 1.0 |
52.4 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 1.0 |
2.0 |
GO:0048747 |
muscle fiber development(GO:0048747) |
| 1.0 |
4.9 |
GO:1904037 |
positive regulation of epithelial cell apoptotic process(GO:1904037) |
| 1.0 |
1.0 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 1.0 |
2.9 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 1.0 |
14.7 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 1.0 |
4.9 |
GO:0010543 |
regulation of platelet activation(GO:0010543) |
| 1.0 |
7.8 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 1.0 |
1.0 |
GO:1990776 |
response to angiotensin(GO:1990776) |
| 1.0 |
2.9 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 1.0 |
3.8 |
GO:0001757 |
somite specification(GO:0001757) |
| 1.0 |
1.9 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 1.0 |
19.2 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 1.0 |
11.4 |
GO:1902475 |
L-alpha-amino acid transmembrane transport(GO:1902475) |
| 1.0 |
2.9 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 1.0 |
1.0 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.9 |
2.8 |
GO:0098760 |
interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
| 0.9 |
3.8 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.9 |
10.4 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.9 |
0.9 |
GO:2000232 |
regulation of rRNA processing(GO:2000232) |
| 0.9 |
6.6 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.9 |
4.7 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.9 |
0.9 |
GO:0050655 |
dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.9 |
6.6 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.9 |
0.9 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.9 |
1.9 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.9 |
0.9 |
GO:1903056 |
regulation of melanosome organization(GO:1903056) |
| 0.9 |
0.9 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
| 0.9 |
8.4 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.9 |
2.8 |
GO:2000269 |
regulation of fibroblast apoptotic process(GO:2000269) |
| 0.9 |
5.5 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.9 |
17.3 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.9 |
0.9 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.9 |
1.8 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.9 |
1.8 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.9 |
9.9 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.9 |
0.9 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.9 |
8.0 |
GO:0042634 |
regulation of hair cycle(GO:0042634) |
| 0.9 |
2.7 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.9 |
4.4 |
GO:0050770 |
regulation of axonogenesis(GO:0050770) |
| 0.9 |
44.3 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.9 |
0.9 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.8 |
10.9 |
GO:0007272 |
ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
| 0.8 |
1.7 |
GO:0006865 |
amino acid transport(GO:0006865) |
| 0.8 |
2.5 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.8 |
1.6 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.8 |
1.6 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.8 |
7.4 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.8 |
0.8 |
GO:0045144 |
meiosis II(GO:0007135) meiotic sister chromatid segregation(GO:0045144) |
| 0.8 |
2.4 |
GO:1905097 |
regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
| 0.8 |
0.8 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 0.8 |
4.8 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.8 |
2.4 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.8 |
2.4 |
GO:0018874 |
benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 0.8 |
42.8 |
GO:0050906 |
detection of stimulus involved in sensory perception(GO:0050906) |
| 0.8 |
2.3 |
GO:0097056 |
seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.8 |
2.3 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.8 |
9.9 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.8 |
3.8 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.8 |
3.8 |
GO:0010623 |
programmed cell death involved in cell development(GO:0010623) |
| 0.8 |
0.8 |
GO:0045639 |
positive regulation of myeloid cell differentiation(GO:0045639) |
| 0.7 |
3.7 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.7 |
8.7 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.7 |
0.7 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.7 |
9.4 |
GO:1900077 |
negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.7 |
15.1 |
GO:0007187 |
G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
| 0.7 |
6.5 |
GO:0014911 |
positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.7 |
2.2 |
GO:0051937 |
catecholamine transport(GO:0051937) |
| 0.7 |
1.4 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.7 |
2.1 |
GO:0009217 |
purine deoxyribonucleotide catabolic process(GO:0009155) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) dATP catabolic process(GO:0046061) |
| 0.7 |
1.4 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.7 |
13.5 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.7 |
2.1 |
GO:0009258 |
10-formyltetrahydrofolate metabolic process(GO:0009256) 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.7 |
2.1 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.7 |
2.1 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.7 |
1.4 |
GO:0048670 |
regulation of collateral sprouting(GO:0048670) |
| 0.7 |
2.0 |
GO:0070120 |
ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.7 |
0.7 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.7 |
3.4 |
GO:0016553 |
base conversion or substitution editing(GO:0016553) cytidine to uridine editing(GO:0016554) |
| 0.7 |
2.7 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.7 |
2.0 |
GO:0070528 |
protein kinase C signaling(GO:0070528) |
| 0.7 |
12.1 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.7 |
0.7 |
GO:0007569 |
cell aging(GO:0007569) |
| 0.7 |
0.7 |
GO:0006711 |
estrogen catabolic process(GO:0006711) |
| 0.7 |
12.5 |
GO:0042100 |
B cell proliferation(GO:0042100) |
| 0.7 |
0.7 |
GO:0070640 |
vitamin D3 metabolic process(GO:0070640) |
| 0.7 |
3.3 |
GO:0019464 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.7 |
2.6 |
GO:0097035 |
regulation of membrane lipid distribution(GO:0097035) |
| 0.6 |
5.2 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.6 |
0.6 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.6 |
1.9 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.6 |
1.2 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.6 |
1.2 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.6 |
1.2 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.6 |
9.8 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.6 |
12.1 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.6 |
1.2 |
GO:0042490 |
mechanoreceptor differentiation(GO:0042490) |
| 0.6 |
5.3 |
GO:0051496 |
positive regulation of stress fiber assembly(GO:0051496) |
| 0.6 |
2.9 |
GO:0018108 |
peptidyl-tyrosine phosphorylation(GO:0018108) peptidyl-tyrosine modification(GO:0018212) |
| 0.6 |
8.2 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.6 |
5.9 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.6 |
12.9 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.6 |
2.3 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.6 |
0.6 |
GO:0032108 |
negative regulation of macroautophagy(GO:0016242) negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
| 0.6 |
2.3 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.6 |
2.8 |
GO:0030207 |
chondroitin sulfate catabolic process(GO:0030207) |
| 0.6 |
3.3 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.6 |
2.8 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.5 |
1.6 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.5 |
1.1 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.5 |
0.5 |
GO:0048592 |
eye morphogenesis(GO:0048592) |
| 0.5 |
3.3 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.5 |
1.6 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.5 |
21.1 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.5 |
22.1 |
GO:0006024 |
aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.5 |
2.1 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.5 |
2.1 |
GO:0045124 |
regulation of bone resorption(GO:0045124) |
| 0.5 |
9.3 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.5 |
1.0 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.5 |
3.1 |
GO:0055017 |
cardiac muscle tissue growth(GO:0055017) heart growth(GO:0060419) |
| 0.5 |
4.0 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.5 |
2.0 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 0.5 |
0.5 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.5 |
1.0 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.5 |
0.5 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.5 |
2.4 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.5 |
2.8 |
GO:0035176 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.5 |
2.3 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.5 |
4.2 |
GO:0050927 |
positive regulation of positive chemotaxis(GO:0050927) |
| 0.5 |
1.4 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.5 |
5.5 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.5 |
0.5 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.5 |
1.8 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.5 |
5.9 |
GO:0035904 |
aorta development(GO:0035904) |
| 0.4 |
0.4 |
GO:0002819 |
regulation of adaptive immune response(GO:0002819) |
| 0.4 |
4.0 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.4 |
4.4 |
GO:0007507 |
heart development(GO:0007507) |
| 0.4 |
0.4 |
GO:1903020 |
positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.4 |
1.3 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.4 |
3.5 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.4 |
1.7 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.4 |
2.6 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.4 |
2.2 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.4 |
5.1 |
GO:0035914 |
skeletal muscle cell differentiation(GO:0035914) |
| 0.4 |
3.8 |
GO:0051354 |
negative regulation of oxidoreductase activity(GO:0051354) |
| 0.4 |
5.9 |
GO:0043401 |
steroid hormone mediated signaling pathway(GO:0043401) |
| 0.4 |
1.3 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
| 0.4 |
0.4 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.4 |
0.8 |
GO:0002719 |
negative regulation of cytokine production involved in immune response(GO:0002719) |
| 0.4 |
0.8 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.4 |
1.2 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.4 |
5.9 |
GO:0034394 |
protein localization to cell surface(GO:0034394) |
| 0.4 |
0.4 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.4 |
1.1 |
GO:0045061 |
thymic T cell selection(GO:0045061) |
| 0.4 |
2.3 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.4 |
4.2 |
GO:0015800 |
acidic amino acid transport(GO:0015800) |
| 0.4 |
8.0 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.3 |
0.7 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.3 |
0.7 |
GO:0043302 |
positive regulation of mast cell activation(GO:0033005) positive regulation of leukocyte degranulation(GO:0043302) |
| 0.3 |
0.7 |
GO:0016049 |
cell growth(GO:0016049) |
| 0.3 |
2.0 |
GO:0033077 |
T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
| 0.3 |
1.0 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.3 |
6.6 |
GO:0006954 |
inflammatory response(GO:0006954) |
| 0.3 |
0.3 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
| 0.3 |
0.3 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.3 |
2.1 |
GO:2000582 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.3 |
1.2 |
GO:0035315 |
hair cell differentiation(GO:0035315) |
| 0.3 |
3.3 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.3 |
1.5 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.3 |
2.0 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.3 |
1.4 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.3 |
3.1 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.3 |
0.6 |
GO:0061053 |
somite development(GO:0061053) |
| 0.3 |
1.7 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.3 |
0.3 |
GO:0010001 |
glial cell differentiation(GO:0010001) |
| 0.3 |
0.8 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.3 |
3.8 |
GO:0006835 |
dicarboxylic acid transport(GO:0006835) |
| 0.3 |
1.0 |
GO:0007628 |
adult walking behavior(GO:0007628) |
| 0.2 |
1.7 |
GO:0046463 |
neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.2 |
0.5 |
GO:0043201 |
response to leucine(GO:0043201) |
| 0.2 |
6.6 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.2 |
0.9 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.2 |
0.5 |
GO:0021772 |
olfactory bulb development(GO:0021772) |
| 0.2 |
3.4 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.2 |
4.6 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.2 |
0.4 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
| 0.2 |
2.4 |
GO:0006067 |
ethanol metabolic process(GO:0006067) |
| 0.2 |
0.4 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.2 |
0.6 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.2 |
1.9 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.2 |
0.2 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.2 |
0.2 |
GO:0035150 |
regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
| 0.2 |
7.0 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.2 |
2.5 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.2 |
0.6 |
GO:0009948 |
anterior/posterior axis specification(GO:0009948) |
| 0.2 |
1.1 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.2 |
0.4 |
GO:0035437 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.2 |
0.4 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.2 |
1.0 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.2 |
0.6 |
GO:0046348 |
amino sugar catabolic process(GO:0046348) |
| 0.1 |
0.7 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 0.1 |
0.1 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.1 |
0.3 |
GO:0017156 |
calcium ion regulated exocytosis(GO:0017156) |
| 0.1 |
0.4 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 0.1 |
0.6 |
GO:0097466 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.1 |
1.9 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.1 |
0.5 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.8 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
0.6 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.1 |
0.4 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 |
0.1 |
GO:0014010 |
regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
| 0.1 |
0.7 |
GO:0035137 |
hindlimb morphogenesis(GO:0035137) |
| 0.1 |
0.5 |
GO:0044598 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
2.3 |
GO:0006687 |
glycosphingolipid metabolic process(GO:0006687) |
| 0.1 |
0.3 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
0.4 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 |
0.1 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.2 |
GO:0019935 |
cyclic-nucleotide-mediated signaling(GO:0019935) |
| 0.0 |
0.1 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.0 |
0.6 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 |
0.1 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) depyrimidination(GO:0045008) |
| 0.0 |
0.0 |
GO:1903365 |
regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
